id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1980-N-0074-0090,FDA,FDA-1980-N-0074,Meeting Minutes - Listening Session with CHPA re Anticaries Drug Product Monograph 2023-07-25,Other,Minutes,2023-08-09T04:00:00Z,2023,8,2023-08-09T04:00:00Z,,2023-08-09T19:06:31Z,,0,0,0900006485e05841
FDA-1980-N-0074-0088,FDA,FDA-1980-N-0074,Citizen Petition from The Proctor and Gamble Company,Other,Citizen Petition,2023-05-09T04:00:00Z,2023,5,2023-05-09T04:00:00Z,,2023-05-09T21:00:13Z,,0,0,09000064859e9884
FDA-1980-N-0074-0089,FDA,FDA-1980-N-0074,Response Letter from FDA CDER to The Proctor & Gamble Company,Other,Denial of Petition,2023-05-09T04:00:00Z,2023,5,2023-05-09T04:00:00Z,,2023-05-09T21:00:19Z,,0,0,09000064859e9f59
FDA-1980-N-0074-0087,FDA,FDA-1980-N-0074,Meeting Minutes - Listening Session with PETA re Anticaries Drug Product Monograph 2022-01-21,Other,Minutes,2022-04-13T04:00:00Z,2022,4,2022-04-13T04:00:00Z,,2022-04-13T13:52:07Z,,0,0,09000064850158c8
FDA-1980-N-0074-0086,FDA,FDA-1980-N-0074,Supplement from Procter & Gamble,Supporting & Related Material,Background Material,2015-04-23T04:00:00Z,2015,4,,,2015-04-23T15:14:41Z,,0,0,0900006481ab4271
FDA-1980-N-0074-0083,FDA,FDA-1980-N-0074,The Procter & Gamble Company - Citizen Petition,Other,CP-Citizen Petition,2009-03-22T04:00:00Z,2009,3,2009-03-22T04:00:00Z,,2013-07-27T22:39:17Z,,0,0,09000064808e63d3
FDA-1980-N-0074-0084,FDA,FDA-1980-N-0074,"Appendix A - ""Publications Citing The Use Of The pH Cycling Model"" - [The Procter & Gamble Company - Citizen Petition] re FDA-1980-N-0074-0083",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2009-03-22T04:00:00Z,2009,3,,,2009-03-23T03:00:36Z,,0,0,09000064808e9df4
FDA-1980-N-0074-0085,FDA,FDA-1980-N-0074,Acknowledgement Letter to The Procter & Gamble Company,Other,ACK-Acknowledgement Letter,2009-03-22T04:00:00Z,2009,3,2009-03-22T04:00:00Z,,2009-03-23T02:59:22Z,,0,0,09000064808ea474
FDA-1980-N-0074-0082,FDA,FDA-1980-N-0074,FDA/ORA to Colgate-Palmolive Company,Other,PDN-Petition Denial,2006-12-11T05:00:00Z,2006,12,,,2008-05-30T22:52:54Z,,0,0,09000064805bb550
FDA-1980-N-0074-0078,FDA,FDA-1980-N-0074,HFD-560 to Pfizer Consumer Healthcare,Other,LET-Letter,2003-01-10T05:00:00Z,2003,1,,,2008-05-30T22:52:25Z,,0,0,09000064805bb53d
FDA-1980-N-0074-0077,FDA,FDA-1980-N-0074,HFD-560 and Consumer Healthcare Prod Assn.,Other,MM-Memorandum of Meeting,2002-09-17T04:00:00Z,2002,9,,,2008-05-30T22:52:25Z,,0,0,09000064805bb535
FDA-1980-N-0074-0076,FDA,FDA-1980-N-0074,FDA,Notice,NEC-Notice of Extension,2002-03-19T05:00:00Z,2002,3,2002-03-19T05:00:00Z,2002-07-13T03:59:59Z,2008-05-30T22:52:54Z,,0,0,09000064805bb4e0
FDA-1980-N-0074-0075,FDA,FDA-1980-N-0074,FDA/ORA to Colgate-Palmolive Company,Other,PDN-Petition Denial,2001-11-14T05:00:00Z,2001,11,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4db
FDA-1980-N-0074-0074,FDA,FDA-1980-N-0074,FDA,Notice,N-Notice,2001-10-22T04:00:00Z,2001,10,2001-10-22T04:00:00Z,2002-01-15T04:59:59Z,2008-05-30T22:53:09Z,,0,0,09000064805bb4da
FDA-1980-N-0074-0073,FDA,FDA-1980-N-0074,"FDA/ORA to Hyman, Phelps & McNamara, P. C.",Other,PDN-Petition Denial,2001-07-09T04:00:00Z,2001,7,,,2008-05-30T22:53:22Z,,0,0,09000064805bb4d8
FDA-1980-N-0074-0072,FDA,FDA-1980-N-0074,HFD-560 to Warner Lambert Consumer Healthcare,Other,LET-Letter,2001-06-28T04:00:00Z,2001,6,,,2008-05-30T22:53:09Z,,0,0,09000064805bb4d7
FDA-1980-N-0074-0071,FDA,FDA-1980-N-0074,HFD-560,Other,MM-Memorandum of Meeting,2000-08-09T04:00:00Z,2000,8,,,2008-05-30T22:52:54Z,,0,0,09000064805bb4d0
FDA-1980-N-0074-0070,FDA,FDA-1980-N-0074,HFD-560,Other,MM-Memorandum of Meeting,2000-06-28T04:00:00Z,2000,6,,,2008-05-30T22:53:02Z,,0,0,09000064805bb4cf
FDA-1980-N-0074-0069,FDA,FDA-1980-N-0074,"HFD-560, CDER HFD-105 and Warner Lambert",Other,MM-Memorandum of Meeting,2000-04-27T04:00:00Z,2000,4,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4c7
FDA-1980-N-0074-0068,FDA,FDA-1980-N-0074,"HFD-560 , Warner Lambert, Consumer Healthcare Prod., CTFA, FDC Reports",Other,MM-Memorandum of Meeting,1999-12-08T05:00:00Z,1999,12,,,2008-05-30T22:52:47Z,,0,0,09000064805bb4ba
FDA-1980-N-0074-0067,FDA,FDA-1980-N-0074,"FDA/CDER to Kleinfeld, Kaplan and Becker",Other,PDN-Petition Denial,1999-09-14T04:00:00Z,1999,9,,,2008-05-30T22:53:22Z,,0,0,09000064805bb4a5
FDA-1980-N-0074-0066,FDA,FDA-1980-N-0074,HFD-560 to Consumer Healthcare Products Association,Other,LET-Letter,1999-05-06T04:00:00Z,1999,5,,,2008-05-30T22:52:54Z,,0,0,09000064805bb498
FDA-1980-N-0074-0065,FDA,FDA-1980-N-0074,HFA-305 to Colgate-Palmolive Company,Other,ACK-Acknowledgement Letter,1999-01-08T05:00:00Z,1999,1,,,2008-05-30T22:53:16Z,,0,0,09000064805bb495
FDA-1980-N-0074-0064,FDA,FDA-1980-N-0074,HFA-305 to Kleinfeld Kaplan & Becker,Other,ACK-Acknowledgement Letter,1998-08-27T04:00:00Z,1998,8,,,2008-05-30T22:52:38Z,,0,0,09000064805bb491
FDA-1980-N-0074-0063,FDA,FDA-1980-N-0074,"HFD-560 to Hyman Phelps & McNamara, P. C.",Other,LET-Letter,1998-07-29T04:00:00Z,1998,7,,,2008-05-30T22:53:09Z,,0,0,09000064805bb48f
FDA-1980-N-0074-0062,FDA,FDA-1980-N-0074,"FDA/ORA to The Cosmetic, Toiletry & Fragrance Association",Other,PDN-Petition Denial,1998-02-06T05:00:00Z,1998,2,,,2008-05-30T22:52:25Z,,0,0,09000064805bb48e
FDA-1980-N-0074-0061,FDA,FDA-1980-N-0074,HFD-560 to Buc & Beardsley,Other,LET-Letter,1997-10-24T04:00:00Z,1997,10,,,2008-05-30T22:52:54Z,,0,0,09000064805bb48c
FDA-1980-N-0074-0060,FDA,FDA-1980-N-0074,HFA-305 to Amway Corporation,Other,ACK-Acknowledgement Letter,1997-10-08T04:00:00Z,1997,10,,,2008-05-30T22:52:54Z,,0,0,09000064805bb48b
FDA-1980-N-0074-0059,FDA,FDA-1980-N-0074,Acknowledgement Letter from FDA HFA 305 to Tom's of Maine,Other,Acknowledgement Letter/Receipt,1997-09-12T04:00:00Z,1997,9,,,2022-05-25T20:47:17Z,,0,0,09000064805bb488
FDA-1980-N-0074-0058,FDA,FDA-1980-N-0074,Letter from FDA to Buc & Beardsly,Other,Letter(s),1997-09-10T04:00:00Z,1997,9,,,2022-05-25T16:50:43Z,,0,0,09000064805bb486
FDA-1980-N-0074-0057,FDA,FDA-1980-N-0074,Citizen Petition Approval Response Letter from FDA/CDER to Tom's of Maine,Other,Approval,1997-09-02T04:00:00Z,1997,9,,,2022-05-25T15:55:24Z,,0,0,09000064805bb484
FDA-1980-N-0074-0056,FDA,FDA-1980-N-0074,Memorandum of Telephone Conversation Between FDA and Tom's of Maine,Other,Memorandum,1997-08-29T04:00:00Z,1997,8,,,2022-05-16T21:06:03Z,,0,0,09000064805bb483
FDA-1980-N-0074-0055,FDA,FDA-1980-N-0074,HFD-560 to Buc & Beardsley,Other,LET-Letter,1997-08-08T04:00:00Z,1997,8,,,2008-05-30T22:53:16Z,,0,0,09000064805bb482
FDA-1980-N-0074-0054,FDA,FDA-1980-N-0074,"Memorandum from FDA CDER to Richard Finn, President Chesebrough-Pond's USA Co.",Other,Memorandum,1997-03-16T05:00:00Z,1997,3,,,2022-05-11T19:57:20Z,,0,0,09000064805bb481
FDA-1980-N-0074-0052,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1997-03-12T05:00:00Z,1997,3,,,2022-05-11T19:42:06Z,,0,0,09000064805bb47f
FDA-1980-N-0074-0053,FDA,FDA-1980-N-0074,"Letter from FDA HFD-560 to Patton Boggs, L. L. P.",Other,Letter(s),1997-03-12T05:00:00Z,1997,3,,,2022-05-11T19:46:26Z,,0,0,09000064805bb480
FDA-1980-N-0074-0051,FDA,FDA-1980-N-0074,Anticaries Drug Products for Over-the-Counter Human Use; Partial Stay of Final Rule; Enforcement Policy,Notice,Notice of Stay of Action,1996-12-20T05:00:00Z,1996,12,,,2022-05-11T16:57:46Z,,0,0,09000064805bb47c
FDA-1980-N-0074-0049,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,LET-Letter,1996-10-15T04:00:00Z,1996,10,,,2022-05-09T20:53:16Z,,0,0,09000064805bb476
FDA-1980-N-0074-0050,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1996-10-15T04:00:00Z,1996,10,,,2022-05-10T18:15:02Z,,0,0,09000064805bb477
FDA-1980-N-0074-0048,FDA,FDA-1980-N-0074,Anticaries Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Partial Delay of Effective Date,Notice,General Notice,1996-10-11T04:00:00Z,1996,10,,,2022-05-09T20:45:25Z,,0,0,09000064805bb475
FDA-1980-N-0074-0047,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Jane Baluss-Buc & Beardsley,Other,Letter(s),1996-10-07T04:00:00Z,1996,10,,,2022-05-09T20:12:01Z,,0,0,09000064805bb474
FDA-1980-N-0074-0044,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1996-07-01T04:00:00Z,1996,7,,,2022-05-02T20:09:11Z,,0,0,09000064805bb462
FDA-1980-N-0074-0045,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1996-07-01T04:00:00Z,1996,7,,,2022-05-02T20:12:18Z,,0,0,09000064805bb463
FDA-1980-N-0074-0046,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1996-07-01T04:00:00Z,1996,7,,,2022-05-02T20:15:21Z,,0,0,09000064805bb464
FDA-1980-N-0074-0042,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1996-06-04T04:00:00Z,1996,6,,,2022-05-02T16:45:51Z,,0,0,09000064805bb45f
FDA-1980-N-0074-0043,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to Nonprescription Drug Manufacturers Association,Other,Letter(s),1996-06-04T04:00:00Z,1996,6,,,2022-05-02T16:48:45Z,,0,0,09000064805bb460
FDA-1980-N-0074-0041,FDA,FDA-1980-N-0074,Letter from FDA HFD-560 to American Dental Association,Other,Letter(s),1996-05-20T04:00:00Z,1996,5,,,2022-05-02T16:30:46Z,,0,0,09000064805bb45d
FDA-1980-N-0074-0040,FDA,FDA-1980-N-0074,Acknowledgement Letter to Nonprescription Drug Manufacturers Association & CTFA (4/18/96),Other,ACK-Acknowledgement Letter,1996-04-18T04:00:00Z,1996,4,,,2009-03-26T20:38:33Z,,0,0,09000064805bb3f2
FDA-1980-N-0074-0038,FDA,FDA-1980-N-0074,Acknowledgement Letter to Nonprescription Drug Manufacturers Association & CTFA (4/18/96),Other,ACK-Acknowledgement Letter,1996-04-18T04:00:00Z,1996,4,,,2009-03-26T20:31:30Z,,0,0,09000064805bb3ee
FDA-1980-N-0074-0039,FDA,FDA-1980-N-0074,Acknowledgement to Nonprescription Drug Manufacturers Association & CFTA (4/18/96),Other,ACK-Acknowledgement Letter,1996-04-18T04:00:00Z,1996,4,,,2009-03-26T20:35:23Z,,0,0,09000064805bb3f0
FDA-1980-N-0074-0037,FDA,FDA-1980-N-0074,Acknowledgement Letter to Nonprescription Drug Manufacturers Association & CTFA (4/18/96),Other,ACK-Acknowledgement Letter,1996-04-18T04:00:00Z,1996,4,,,2009-03-26T18:45:27Z,,0,0,09000064805bb3dc
FDA-1980-N-0074-0036,FDA,FDA-1980-N-0074,Acknowledgement Letter to Tom's of Maine (2/20/96),Other,ACK-Acknowledgement Letter,1996-02-20T05:00:00Z,1996,2,,,2009-03-26T18:41:20Z,,0,0,09000064805bb3d6
FDA-1980-N-0074-0035,FDA,FDA-1980-N-0074,FDA,Notice,NCR-Notice of Correction,1995-12-05T05:00:00Z,1995,12,,,2008-05-30T22:53:09Z,,0,0,09000064805bb3ca
FDA-1980-N-0074-0033,FDA,FDA-1980-N-0074,FDA,Notice,NFR-Notice of Final Rule,1995-11-27T05:00:00Z,1995,11,,,2008-05-30T22:52:47Z,,0,0,09000064805bb3c8
FDA-1980-N-0074-0034,FDA,FDA-1980-N-0074,FDA,Notice,NFR-Notice of Final Rule,1995-11-27T05:00:00Z,1995,11,,,2008-05-30T22:53:02Z,,0,0,09000064805bb3c9
FDA-1980-N-0074-0032,FDA,FDA-1980-N-0074,"Letter from FDA HFD-811 to Cosmetic, Toiletry and Fragrance Association",Other,Letter(s),1995-10-04T04:00:00Z,1995,10,,,2022-04-21T20:23:50Z,,0,0,09000064805bb362
FDA-1980-N-0074-0031,FDA,FDA-1980-N-0074,"Letter from FDA HFD-810 to Church and Dwight Company, Inc.",Other,Letter(s),1994-02-10T05:00:00Z,1994,2,,,2022-04-21T20:25:03Z,,0,0,09000064805bb361